Cancer Nanotechnology

Research on nanotechnology cancer therapy extends beyond drug delivery into the creation of new therapeutics available only through use of nanomaterial properties. Although small compared to cells, nanoparticles are large enough to encapsulate many small molecule compounds, which can be of multiple types. At the same time, the relatively large surface area of nanoparticle can be functionalized with ligands, including small molecules, DNA or RNA strands, peptides, aptamers or antibodies. These ligands can be used for therapeutic effect or to direct nanoparticle fate in vivo. These properties enable combination drug delivery, multi-modality treatment and combined therapeutic and diagnostic, known as “theranostic,” action. The physical properties of nanoparticles, such as energy absorption and re-radiation, can also be used to disrupt diseased tissue, as in laser ablation and hyperthermia applications.

  • Diagnostic Methods
  • Drug Delivery
  • Heart Disease
  • Nanorobots & Therapy Methods

Related Conference of Cancer Nanotechnology

April 29-30, 2020

18th European Pathology and Medicine Congress

Prague, Czech Republic
August 26-27, 2020

World Congress on Histopathology & Cytopathology

Kyoto, Japan
September 16-17, 2020

7th Annual Meet on Cardiology and Heart diseases

Barcelona, Spain
September 24-25, 2020

Global Digital Pathology Summit

Paris, France
October 19-20, 2020

World Congress on Pathology and Microbiology

Manila, Philippines
October 19-20, 2020

Global Pathologists Meet

Manila, Philippines
November 25-26, 2020

18th Asia Pacific Pathology Congress

Tokyo, Japan

Cancer Nanotechnology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in